AMP Europe 2018: AMP NGS Guidelines

Log in for pricing

(No reviews yet) Write a Review
SKU:
311EUR18-008

Please note that this content was created in 2018. In the time since this material was posted, there may have been additional developments, advancements, and/or more current publications in this field.

AMP Education is constantly updating our educational offerings, and will remove or replace content that is no longer accurate. Please be sure to use the search function to find related or updated material available in our catalogue at educate.amp.org. The Training and Education Committee works with AMP Education Programs to bring you the most up-to-date and cutting-edge information on molecular pathology research, applications, and training.


This is a recording of a session from AMP Europe 2018 meeting in Rotterdam. Purchase the entire AMP Europe 2018 Recordings for a significant discount!


In 2017, AMP partnered with various stakeholders to develop and publish two related published guideline manuscripts in The Journal for Molecular Diagnostics: 1) Guidelines for Validation of Next Generation Sequencing (NGS)-based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists and 2) Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. This session will be a discussion of how the guidelines were developed and will provide practical case-based implementation advice for laboratories both currently performing somatic NGS and those considering bringing these technologies into their laboratories.

Practice Guidelines for Validation, Interpretation and Reporting of NGS-Based Oncology Tests 
Marina N. Nikiforova, MD (Pittsburgh, USA)

Objectives:

  • Discuss key points of the guideline for validation of NGS-based oncology tests.
  • Discuss key points of the guideline for the classification, interpretation, and reporting of somatic sequence variants in NGS-based oncology panels.
  • Evaluate utility of these guidelines for development, validation, interpretation and reporting of the laboratory developed NGS tests using clinical case scenarios.

Duration: 0.75 hr
Recording Date: May 1, 2018

Last day to purchase: December 31, 2021

There are no CME/CMLE or SAMs credits available.

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.